Lazard Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-141,208	Closed	-$458K	–	1843
2019 Q4	$458K	Buy	+141,208	New	+$410K	﹤0.01%	819
2016 Q2	–	Sell	-4,043	Closed	-$13K	–	1157
2016 Q1	$13K	Buy	+4,043	New	+$12.6K	﹤0.01%	941
2015 Q2	–	Sell	-282,653	Closed	-$1.99M	–	1232
2015 Q1	$1.99M	Sell	282,653 -14,367	-5%	-$104K	﹤0.01%	638
2014 Q4	$2.29M	Sell	297,020 -60,000	-17%	-$475K	﹤0.01%	643
2014 Q3	$2.67M	Buy	357,020 +51,420	+17%	+$477K	0.01%	588
2014 Q2	$2.96M	Sell	305,600 -63,894	-17%	-$569K	0.01%	592
2014 Q1	$3.07M	Buy	369,494 +274,415	+289%	+$2.35M	0.01%	546
2013 Q4	$802K	Buy	95,079 +45,079	+90%	+$380K	﹤0.01%	726
2013 Q3	$398K	Buy	+50,000	New	+$402K	﹤0.01%	751